VIENNA (MedPage Today) -- The newest class of diabetes medications, the SGLT2 inhibitors, were good at controlling HbA1c and offered additional benefits of weight loss and greater reductions in blood pressure, researchers said here. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment